中国60位国医大师名单

2014-09-12 佚名 中国中医药报

首届“国医大师”名单及基本情况(按姓氏笔画排名,名字不变颜色的为已辞世)2008年10月由人力资源和社会保障部、原卫生部、国家中医药管理局联合启动了首届“国医大师”的评选活动。2009年5月发布了《关于表彰首届“国医大师”的决定》,表彰了首批30位国医大师。1. 王玉川,男,汉族,1923年9月出生,北京中医药大学主任医师、教授,1943年3月起从事中医临床工作,为“首都国医名师”。2. 王绵

首届“国医大师”名单及基本情况
(按姓氏笔画排名,名字不变颜色的为已辞世)


2008年10月由人力资源和社会保障部、原卫生部、国家中医药管理局联合启动了首届“国医大师”的评选活动。2009年5月发布了《关于表彰首届“国医大师”的决定》,表彰了首批30位国医大师。


1. 王玉川,男,汉族,1923年9月出生,北京中医药大学主任医师、教授,1943年3月起从事中医临床工作,为“首都国医名师”。
2. 王绵之,男,汉族,1923年10月出生,北京中医药大学主任医师、教授,1942年1月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、“首都国医名师”,国家级非物质文化遗产传统医药项目代表性传承人。
3. 方和谦,男,汉族,1923年12月出生,首都医科大学附属北京朝阳医院主任医师、教授,1948年8月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师、“首都国医名师”。
4. 邓铁涛,男,汉族,1916年11月出生,广州中医药大学主任医师、教授,1938年9月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、广东省名老中医,国家级非物质文化遗产传统医药项目代表性传承人。
5. 朱良春,男,汉族,1917年8月出生,南通市中医院主任医师、教授,1939年1月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、江苏省名中医。
6. 任继学,男,汉族,1926年1月出生,长春中医药大学附属医院主任医师,1945 年4月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、吉林省名老中医。
7. 苏荣扎布,男,蒙古族,1929年12月出生,内蒙古医学院主任医师、教授,1949年5月起从事蒙医临床工作,全国老中医药专家学术经验继承工作指导老师、自治区名蒙医。
8. 李玉奇,男,汉族,1917年8月出生,辽宁中医药大学附属医院主任医师,1939 年3月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师。
9. 李济仁,男,汉族,1931年1月出生,皖南医学院附属弋矶山医院主任医师、教授,1948年11月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、安徽省名老中医。
10. 李振华,男,汉族,1924年11月出生,河南中医学院主任医师、教授,1943年3月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师。
11. 李辅仁,男,汉族,1919年6月出生,卫生部北京医院主任医师,1941年起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、“首都国医名师”。
12. 吴咸中,男,满族,1925年8月出生,天津医科大学、天津市南开医院主任医师、教授,中国工程院院士,1951年起即用中医药治疗常见病症,全国老中医药专家学术经验继承工作指导老师。
13. 何任,男,汉族,1921年1月出生,浙江中医药大学主任医师、教授,1941年1月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、浙江省名中医。
14. 张琪,男,汉族,1922年12月出生,黑龙江省中医研究院主任医师,1942年1月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、黑龙江省名老中医。 
15. 张灿玾,男,汉族,1928年7月出生,山东中医药大学主任医师、教授,1949 年1月起从事中医临床工作,为山东省名中医药专家。
16. 张学文,男,汉族,1935年10月出生,陕西中医学院主任医师、教授,1953 年 5 月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师。
17. 张镜人,男,汉族,1923年6月出生,上海市第一人民医院主任医师、教授,1942 年6月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师、上海市名中医。
18. 陆广莘,男,汉族,1927年1月出生,中国中医科学院主任医师,1948年10月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师。
19. 周仲瑛,男,汉族,1928年6月出生,南京中医药大学主任医师、教授,1948年1月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师,国家级非物质文化遗产传统医药项目代表性传承人、江苏省名中医。
20. 贺普仁,男,汉族,1926年5月出生,首都医科大学附属北京中医医院主任医师、教授,1948年起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师、“首都国医名师”,国家级非物质文化遗产传统医药项目代表性传承人。
21. 班秀文,男,壮族,1920年1月出生,广西中医学院主任医师、教授,1940年9月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师。
22. 徐景藩,男,汉族,1928年1月出生,江苏省中医院主任医师、教授,1946年6月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、江苏省名中医。
23. 郭子光,男,汉族,1932年12月出生,成都中医药大学主任医师、教授,1951年4月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师。
24. 唐由之,男,汉族,1926年7月出生,中国中医科学院主任医师、研究员,1946年起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、“首都国医名师”。
25. 程莘农,男,汉族,1921年8月出生,中国中医科学院主任医师、教授,中国工程院院士,1939年2月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、“首都国医名师”。
26. 强巴赤列,男,藏族,1929出生,西藏自治区藏医院主任医师,1947年起从事藏医临床工作,为全国老中医药专家学术经验继承工作指导老师、自治区名藏医。
27. 裘沛然,男,汉族,1913年1月出生,上海中医药大学主任医师、教授,1934年9月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、上海市名中医。
28. 路志正,男,汉族,1920年12月出生,中国中医科学院主任医师,1939年2月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、“首都国医名师”,国家级非物质文化遗产传统医药项目代表性传承人。
29. 颜正华,男,汉族,1920年2月,北京中医药大学主任医师、教授,1940年7月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、“首都国医名师”,国家级非物质文化遗产传统医药项目代表性传承人。
30. 颜德馨,男,汉族,1920年11月出生,同济大学附属第十人民医院主任医师,1939年8月起从事中医临床工作,为全国老中医药专家学术经验继承工作指导老师、上海市名中医,国家级非物质文化遗产传统医药项目代表性传承人。(原载国家中医药管理局官方网站)


第二批“国医大师”名单

(共30名,按姓氏笔画排序)


根据《人力资源社会保障部 国家卫生计生委 国家中医药局关于评选第二届国医大师的通知》(人社部函〔2013〕217号)精神,经逐级推荐和评审,并经第二届“国医大师”评选表彰工作领导小组审核,拟授予干祖望等30人“国医大师”荣誉称号并进行表彰,现予以公示。(注:未表彰)


1.干祖望 男,汉族,农工党员,1912年9月生,南京中医药大学附属医院主任中医师、教授。1930年2月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师。


2. 王 琦 男,汉族,中共党员,1943年2月生,北京中医药大学主任医师、终身教授、研究员。1961年9月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师。


3. 巴黑·玉素甫 (1934.7-2014.4)(已逝)男,维吾尔族,中共党员,新疆维吾尔自治区维吾尔医医院主任医师。1956年1月起从事维吾尔医临床工作,全国老中医药专家学术经验继承工作指导老师,新疆维吾尔自治区名中医民族医。


4. 石仰山 男,汉族,中共党员,1931年3月生,上海市黄浦区中心医院名誉院长,主任医师。1950年1月起从事中医临床工作,上海市名中医。


5. 石学敏 男,汉族,中共党员,1938年6月生,中国工程院院士,天津中医药大学第一附属医院名誉院长,主任医师、教授。1962年7月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,天津市名中医。


6. 占 堆 男,藏族,中共党员,1946年5月生,西藏自治区藏医院名誉院长,主任医师。1959年3月起从事藏医临床工作,西藏自治区名藏医。


7. 阮士怡 男,汉族,中共党员,1917年2月生,天津中医药大学第一附属医院主任医师、教授。1955年7月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,天津市名中医。


8. 孙光荣 男,汉族,1941年11月生,北京中医药大学远程教育学院原副院长,主任医师、研究员。1958年7月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师。


9. 刘志明 男,汉族,1927年10月生,中国中医科学院广安门医院主任医师。1940年9月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,首都国医名师。


10. 刘尚义 男,汉族,中共党员,1942年12月生,贵阳中医学院、贵阳中医学院第一附属医院主任医师、教授。1962年1月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,贵州省名中医。


11. 刘祖贻 男,汉族,中共党员,1937年7月生,湖南省中医药研究院研究员。1955年1月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,湖南省名中医。


12. 刘柏龄 男,汉族,中共党员,1927年6月生,长春中医药大学终身教授、主任医师。1948年1月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,吉林省名中医。


13. 吉格木德 男,蒙古族,中共党员,1939年12月生,内蒙古医科大学教授、主任医师。1956年3月起从事蒙医临床工作,全国老中医药专家学术经验继承工作指导老师,内蒙古自治区名蒙医。


14. 刘敏如 女,汉族,农工党员、中共党员,1933年5月生,成都中医药大学教授。1956年9月起从事中医临床工作,四川省名中医。


15. 吕景山 男,汉族,中共党员,1934年11月生,山西中医学院第三中医院(山西省针灸研究所)教授、主任医师。1962年7月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,山西名医。


16. 张大宁 男,汉族,农工党员,1944年9月生,天津市中医药研究院名誉院长,天津市中医肾病研究所所长,主任医师、教授。1959年6月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,天津市名中医。


17. 李士懋 男,汉族,1936年7月生,河北中医学院教授、主任医师。1962年11月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,河北省名中医。


18. 李今庸 男,汉族,1925年9月生,湖北中医药大学教授。1947年12月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,湖北中医大师。


19. 陈可冀 男,汉族,中共党员,1930年10月生,中国科学院院士,中国中医科学院主任医师、首席研究员、终身研究员。1956年4月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师。


20. 金世元 男,汉族,中共党员,1926年12月生,北京卫生职业学院主任药师。1940年2月起从事中医药工作,全国老中医药专家学术经验继承工作指导老师,首都国医名师。


21. 郑 新 男,汉族,中共党员,1925年5月生,重庆市中医院主任医师。1961年8月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师。


22. 尚德俊 男,汉族,中共党员,1932年3月生,山东中医药大学教授,山东省中医院外科主任、主任医师。1959年8月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,山东省名中医药专家。


23. 洪广祥 男,汉族,中共党员,1938年12月生,江西中医药大学教授、主任医师。1956年8月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,江西省名中医。


24. 段富津 男,汉族,中共党员,1930年12月生,黑龙江中医药大学教授。1950年1月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,黑龙江省名老中医。


25. 徐经世 男,汉族,中共党员,1933年1月生,安徽中医药大学第一附属医院主任医师、教授。1952年1月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,安徽省国医名师。


26. 郭诚杰 男,汉族,中共党员,1921年12月生,陕西中医学院教授、主任医师。1949年9月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,陕西省名老中医。


27. 唐祖宣 男,汉族,中共党员,1943年7月生,河南省邓州市中医院院长,主任医师。1958年3月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师。


28. 夏桂成 男,汉族,中共党员,1931年7月生,江苏省中医院主任中医师、教授。1949年10月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,江苏省名中医。


29. 晁恩祥 男,汉族,中共党员,1935年7月生,中日友好医院主任医师、教授。1962年10月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,首都国医名师。


30. 禤国维 男,汉族,中共党员,1937年11月生,广州中医药大学首席教授、主任医师。1963年8月起从事中医临床工作,全国老中医药专家学术经验继承工作指导老师,广东省名中医。



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (23)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=79038, encodeId=78c3e90383e, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:39:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79028, encodeId=fb59e902862, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79027, encodeId=12fae902771, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79029, encodeId=fb53e90298b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79030, encodeId=d028e9030db, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79031, encodeId=6c56e903110, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79032, encodeId=e684e90327b, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79035, encodeId=8ae6e903582, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79037, encodeId=3c87e903784, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=79036, encodeId=045be9036cc, content=发展传统医药事业, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Apr 17 08:38:00 CST 2016, time=2016-04-17, status=1, ipAttribution=)]
    2016-04-17 忠诚向上

    发展传统医药事业

    0